Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model

Glienke, 2015, Advantages and applications of CAR-expressing natural killer cells, Front Pharmacol, 6, 21, 10.3389/fphar.2015.00021 Gill, 2016, Chimeric antigen receptor T cell therapy: 25 years in the making, Blood Rev, 30, 157, 10.1016/j.blre.2015.10.003 Mehta, 2018, Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer, Front Immunol, 9, 283, 10.3389/fimmu.2018.00283 Liu, 2017, Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies, J Hematol Oncol, 10, 35, 10.1186/s13045-017-0405-3 Brudno, 2016, Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease, J Clin Oncol, 34, 1112, 10.1200/JCO.2015.64.5929 Watzl, 2014, How to trigger a killer: modulation of natural killer cell reactivity on many levels, Adv Immunol, 124, 137, 10.1016/B978-0-12-800147-9.00005-4 Lanier, 1998, NK cell receptors, Annu Rev Immunol, 16, 359, 10.1146/annurev.immunol.16.1.359 Olson, 2010, NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects, Blood, 115, 4293, 10.1182/blood-2009-05-222190 Miller, 2005, Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, 105, 3051, 10.1182/blood-2004-07-2974 Ni, 2014, Expression of chimeric receptor CD4zeta by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo, Stem Cells, 32, 1021, 10.1002/stem.1611 Sutlu, 2012, Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy, Hum Gene Ther, 23, 1090, 10.1089/hum.2012.080 Boissel, 2012, Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens, Leuk Lymphoma, 53, 958, 10.3109/10428194.2011.634048 Gong, 1994, Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells, Leukemia, 8, 652 Yagita, 2000, A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, Leukemia, 14, 922, 10.1038/sj.leu.2401769 Robertson, 1996, Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia, Exp Hematol, 24, 406 Cheng, 2012, A new reliable bioassay for determining the biological activity of human interleukin-12 by using human NK cell line NKG cells, Int Immunopharmacol, 13, 109, 10.1016/j.intimp.2012.03.015 James, 2013, Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling, Blood, 121, 2627, 10.1182/blood-2012-06-437012 Maki, 2001, Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92, J Hematother Stem Cell Res, 10, 369, 10.1089/152581601750288975 Tonn, 2013, Treatment of patients with advanced cancer with the natural killer cell line NK-92, Cytotherapy, 15, 1563, 10.1016/j.jcyt.2013.06.017 Romanski, 2005, Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia, Exp Hematol, 33, 344, 10.1016/j.exphem.2004.11.006 Romanski, 2016, CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies, J Cell Mol Med, 20, 1287, 10.1111/jcmm.12810 Boissel, 2013, Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity, Oncoimmunology, 2, e26527, 10.4161/onci.26527 Tam, 1999, Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy, Hum Gene Ther, 10, 1359, 10.1089/10430349950018030 Nowakowska, 2018, Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies, Cancer Immunol Immunother, 67, 25, 10.1007/s00262-017-2055-2 Esser, 2012, NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin, J Cell Mol Med, 16, 569, 10.1111/j.1582-4934.2011.01343.x Zhang, 2019, Natural killer cells and current applications of chimeric antigen receptor-modified NK-92 cells in tumor immunotherapy, Int J Mol Sci, 20, 317, 10.3390/ijms20020317 An, 2016, Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells, Oncotarget, 7, 10638, 10.18632/oncotarget.7079 Xu, 2018, Induced CD20 expression on B-cell malignant cells heightened the cytotoxic activity of chimeric antigen receptor engineered T cells, Hum Gene Ther, 30, 497, 10.1089/hum.2018.119 Xu, 2019, 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies, J Hematol Oncol, 12, 49, 10.1186/s13045-019-0732-7 Xu, 2017, Sox2 communicates with tregs through CCL1 to promote the stemness property of breast cancer cells, Stem Cells, 35, 2351, 10.1002/stem.2720 Evans, 2011, A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG, Eur J Immunol, 41, 1924, 10.1002/eji.201041180 Erokhina, 2018, HLA-DR(+) NK cells are mostly characterized by less mature phenotype and high functional activity, Immunol Cell Biol, 96, 212, 10.1111/imcb.1032 Liu, 2018, Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity, Leukemia, 32, 520, 10.1038/leu.2017.226 Jochems, 2016, An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele, Oncotarget, 7, 86359, 10.18632/oncotarget.13411 Robbins, 2020, Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells, eLife, 9, e54854, 10.7554/eLife.54854 Williams, 2018, CD16(+)NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice, Haematologica, 103, 1720, 10.3324/haematol.2017.187385 Tam, 2003, Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy, Cytotherapy, 5, 259, 10.1080/14653240310001523 Porter, 2018, Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel, J Hematol Oncol, 11, 35, 10.1186/s13045-018-0571-y Widel, 2009, Radiation-induced bystander effect: the important part of ionizing radiation response. Potential clinical implications, Postepy Hig Med Dosw (Online), 63, 377 Xu, 2015, Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect, RNA Biol, 12, 1355, 10.1080/15476286.2015.1100795 Chen, 2020, Treatment of testicular relapse of B-cell acute lymphoblastic leukemia with CD19-specific chimeric antigen receptor T cells., Clin Lymphoma Myeloma Leuk, 20, 366, 10.1016/j.clml.2019.10.016